AXIM BIOTECHNOLOGIES, INC. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, other for the quarter ending 2020-06-30 was $548.00K, a 21.26% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, other for the quarter ending 2020-03-31 was $962.50K, a 39.57% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, other for the quarter ending 2019-09-30 was $111.81K, a 92.79% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, other for the quarter ending 2019-06-30 was $696.00K, a 61.00% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, other for fiscal 2018 was $3.77M.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, other for fiscal 2017 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, other for fiscal 2016 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. stock issued during period, value, other for fiscal 2011 was $13.00K.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2020-06-30 | $548.00K 10-Q · filed 2021-11-22 | |
| 2020-03-31 | $962.50K 10-Q · filed 2021-11-22 | |
| 2019-09-30 | $111.81K 10-Q/A · filed 2020-11-27 | $6.17M derived: sum of 4 quarters · filed 2020-11-27 |
| 2019-06-30 | $696.00K 10-Q/A · filed 2020-11-27 | $7.61M derived: sum of 4 quarters · filed 2020-11-27 |
| 2019-03-31 | $1.59M 10-Q/A · filed 2020-11-27 | $8.70M derived: sum of 4 quarters · filed 2020-11-27 |
| 2018-12-31 | $3.77M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-05-20 | $3.77M 10-K/A · filed 2020-05-20 |
| 2018-09-30 | $1.55M 10-Q · filed 2019-11-14 | $3.34M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $1.78M 10-Q · filed 2019-11-14 | $1.78M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-18 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 10-K · filed 2018-03-15 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-15 | |
| 2011-12-31 | $13.00K 10-K · filed 2013-04-15 |